[Clinical studies of a new type of antacid: effects on ph of the gastric secretion and on symptoms of dyspepsia in patients with gastro-duodenal disorders].
D000863:Antacids / Q000494:pharmacology* / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D002119:Calcium Carbonate / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004378:Duodenal Diseases / Q000188:drug therapy; D004415:Dyspepsia / Q000188:drug therapy*; D005750:Gastric Juice / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008277:Magnesium Oxide / Q000627:therapeutic use; D013272:Stomach Diseases / Q000188:drug therapy
D000863:Antacids; D001639:Bicarbonates; D004338:Drug Combinations; D008277:Magnesium Oxide; D002119:Calcium Carbonate; D001729:Bismuth
Osservazioni cliniche su un antiacido di nuova concezione: effetti sul pH del secreto gastrico e sulla sintomatologia dispeptica in gastro-duodeno-pazienti